| medinfo ( @ 2007-10-16 06:58:00 |
Save Your Cash, Pfizer
</a>
Motley Fool - And sales from Pfizer's $1.6 billion-a-year antihistamine Zyrtec are about to start evaporating in 2007. Even before Lipitor's U.S. patents begin to expire in 2010, Pfizer's top-line growth is already stuck in a rut. To combat this drain on its net
</a>
Motley Fool - And sales from Pfizer's $1.6 billion-a-year antihistamine Zyrtec are about to start evaporating in 2007. Even before Lipitor's U.S. patents begin to expire in 2010, Pfizer's top-line growth is already stuck in a rut. To combat this drain on its net